Axid · DIN 00778338 · 150 mg · capsule
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Axid · DIN 00778338
Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 1996-10-01
Health Canada: Marketed since 2013-09-26 · brand AXID · ATC A02BA04 NIZATIDINE · form Capsule · route Oral · ingredients NIZATIDINE 150 MG · company Pendopharm division of pharmascience inc · schedule Prescription
Axid: Formulary list price $0.90 per unit (the source does not state the unit; exact figure $0.9047). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00778338)
Source record
DIN 00778338: Axid
Raw flags: chronicUseMed=Y, sec3=Y
Item: 564000027; group id 686; item number 1706; lccId None; manufacturer id PEN
Source form: Cap; strength: 150mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.9047; ministry $0.9047
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00778338
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8915
Shortage status: not checked (no credentials)